Disease | multiple endocrine neoplasia type 1 |
Comorbidity | C0027947|neutropenia |
Sentences | 1 |
PubMedID- 21448449 | The most common toxicity in both treatment arms was neutropenia (82% of men in the cabazitaxel group and 58% in the mitoxantrone group experienced ≥grade 3 toxicity). |
Page: 1